Assessment of Public Opinion on Transparency at the US Food and Drug Administration

This survey study assesses public support for or opposition to transparency measures regarding the US Food and Drug Administration (FDA) drug approval process.

Detalles Bibliográficos
Autores principales: Azad, Tej D., Plott, Caroline F., Gielen, Andrea C., Sharfstein, Joshua M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857683/
https://www.ncbi.nlm.nih.gov/pubmed/35179590
http://dx.doi.org/10.1001/jamanetworkopen.2022.0026
Descripción
Sumario:This survey study assesses public support for or opposition to transparency measures regarding the US Food and Drug Administration (FDA) drug approval process.

Ejemplares similares